Diagnostics of hypertensive disorders in cardio-obstetrics: current state-of-affairs
Russian Journal of Human Reproduction,
Journal Year:
2025,
Volume and Issue:
31(1), P. 63 - 63
Published: March 12, 2025
The
emergence
of
the
term
“cardioobstetrics”
in
modern
medical
literature
is
associated
with
high
relevance
cardiovascular
problems
during
pregnancy
and
postpartum,
leading
many
cases
to
maternal
perinatal
mortality
morbidity,
as
well
increased
risk
later
life.
authors
most
reviews
on
cardioobstetrics
try
cover
all
this
field
medicine
completely
possible
one
article,
which
makes
disclosure
specific
issues
incomplete.
Our
review
provides,
our
opinion,
comprehensive
information
applied
issue
—
diagnosis
hypertensive
disorders
postpartum
period.
paper
evaluates
methodological
approaches
based
primarily
analysis
Russian
foreign
clinical
recommendations,
other
key
data.
In
particular,
use
office
out-of-office
methods
for
blood
pressure
measuring
considered.
As
a
result
analysis,
clear
easy-to-understand
flowcharts
diagnosing
were
proposed.
Language: Английский
Personalized approach to the treatment of patients with arterial hypertension: focus on imidazoline receptor agonists. Opinion on the problem
CARDIOVASCULAR THERAPY AND PREVENTION,
Journal Year:
2025,
Volume and Issue:
24(2), P. 4342 - 4342
Published: March 17, 2025
Hypertension
(HTN)
remains
one
of
the
most
pressing
problems
modern
healthcare.
Morbidity
and
mortality
associated
with
HTN
continue
to
increase,
despite
a
wide
range
available
antihypertensive
agents
regular
updates
related
clinical
guidelines.
In
October
2024,
an
annual
forum
was
held
discuss
optimization
approaches
treatment
HTN.
During
discussion,
special
attention
paid
personalized
therapy
patients,
which
should
be
based
on
concepts
disease
pathogenesis
individual
risk
factors.
addition,
validity
prescribing
imidazoline
receptor
agonists,
are
additional
that
lower
blood
pressure,
in
certain
situations
discussed,
along
main
five
classes
drugs.
routine
practice,
it
is
recommended
consider
use
centrally
acting
drugs,
particular
moxonidine,
control
hypertension
as
part
combination
therapy.
A
central
sympathetic
inhibition
moxonidine
ensures
pressure
has
pleiotropic
effects,
among
important
increase
tissue
sensitivity
insulin.
This
especially
for
patients
obesity,
metabolic
syndrome,
prediabetes,
type
2
diabetes,
various
disorders
(hyperglycemia,
dyslipidemia,
hyperuricemia)
women
peri-
postmenopausal
period.
Language: Английский
Adherence, safety, efficacy – three pillars of hypertension treatment with fixed dose combinations
Systemic Hypertension,
Journal Year:
2024,
Volume and Issue:
21(4), P. 121 - 127
Published: Dec. 26, 2024
Objective.
ToGlobally
more
than
1.4
billion
people
have
hypertension,
of
whom
less
15%
their
blood
pressure
appropriately
controlled
(BP),
and
that
is
the
leading
cause
death
globally.
In
low-
middle-income
countries,
70%
treated
patients
uncontrolled
hypertension.
One
major
reasons
for
poor
control
reliable
patient
adherence
to
treatment.
fixed-dose
combinations,
which
incorporate
two
antihypertensive
drugs
or
can
improve
rates
BP
without
increasing
risk
adverse
events,
thereby
prevent
complications
The
advantages
fixed
combinations
from
Canonpharma
Production
are
proven
bioequivalence
reference
drugs,
good
tolerability,
ease
use
lower
cost
compared
original
drugs.
represented
by
several
two-
three-component
in
various
dosages,
help
physician
prescribe
escalate
therapy.
Language: Английский
The influence of epigenetic regulation on development of multifactorial diseases
N. V. Vokhmyanina,
No information about this author
Natalya E. Golovanova
No information about this author
Russian Family Doctor,
Journal Year:
2024,
Volume and Issue:
28(4), P. 39 - 49
Published: Dec. 15, 2024
Multifactorial
diseases
pose
a
growing
challenge
to
global
healthcare
due
their
rapidly
increasing
prevalence,
high
mortality
rates,
and
significant
contribution
disability
among
the
working-age
population.
Intensive
research
aimed
at
improving
early
diagnosis,
prevention,
treatment
has
underscored
critical
role
of
epigenetic
changes,
which
influence
gene
expression
without
altering
primary
DNA
sequence.
This
article
provides
an
overview
mechanisms
involved
in
regulation,
including
methylation,
post-translational
histone
modifications,
non-coding
microRNAs
silencing.
Epigenetic
factors
serve
as
bridge
between
genome
environmental
influences.
Environmental
risk
factors—shaped
by
lifestyle,
behavior,
ecological
exposures,
psycho-emotional
stress—play
phenotypic
manifestations
overall
human
health.
The
reversibility
regulating
can
lead
both
beneficial
adverse
health
outcomes.
continuous
development
new
technologies
positions
epigenetics
promising
field
for
functional
research,
with
potential
fundamentally
transform
therapeutic
approaches
multifactorial
diseases.
Language: Английский